Session 2: Expanding Frontiers of Genomic Medicine Enabled by Cost-Effective Next Generation Sequencing

Whole genome bisulfite sequencing (WGBS) enables a comprehensive analysis of an individual's DNA methylation profile and has the potential to enhance precision medicine initiatives by addressing both genetic and epigenetic factors simultaneously. Collecting DNA methylation data by WGBS offers valuable insights into disease origin, predisposition, and treatment response, potentially guiding therapeutic strategies. | Whole genome bisulfite sequencing (WGBS) enables a comprehensive analysis of an individual's DNA methylation profile and has the potential to enhance precision medicine initiatives by addressing both genetic and epigenetic factors simultaneously.

A perspective on translating genomic discoveries into targets for brain‐machine interface and deep brain stimulation devices - Valentim - WIREs Mechanisms of Disease - Wiley Online Library

AI in Genomics and Reporting for Clinical Practice

Cool Companies - Connect San Diego

How Declining Sequencing Costs Effects Clinical Genetics?

Frontiers The Role of the European Society of Human Genetics in Delivering Genomic Education

Frontiers From the patient to the population: Use of genomics for population screening

Next-generation sequencing and molecular therapy

Newborn screening: What advances are unlocking new medical interventions? - PreScouter-Custom Intelligence from a Global Network of Experts % %

Next Generation Sequencing for Clinical Diagnostics-Principles and Application to Targeted Resequencing for Hypertrophic Cardiomyopathy: A Paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology - ScienceDirect

Frontiers A Department of Defense Laboratory Consortium Approach to Next Generation Sequencing and Bioinformatics Training for Infectious Disease Surveillance in Kenya